Shares of Midatech Pharma plc (LON:MTPH) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 26.05 ($0.34) and traded as high as GBX 27.19 ($0.36). Midatech Pharma shares last traded at GBX 26.25 ($0.34), with a volume of 110,600 shares trading hands.
The company has a debt-to-equity ratio of 5.00, a current ratio of 3.10 and a quick ratio of 3.02. The business has a 50-day simple moving average of GBX 26.05 and a 200-day simple moving average of GBX 28.39. The firm has a market capitalization of £26.00 million and a PE ratio of -0.51.
Midatech Pharma Company Profile (LON:MTPH)
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications.
Featured Story: What are the advantages of the Stochastic Momentum Index?
Receive News & Ratings for Midatech Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Midatech Pharma and related companies with MarketBeat.com's FREE daily email newsletter.